Three companies conspired to keep a Korean competitor out of the U.S. rubber and plastics market, a complaint filed Thursday in a federal court in Los Angeles alleged.
A small biotech company has won a permanent injunction against Eli Lilly & Co. in a two-year battle waged over a patent application for technology used to convert injectable-only drugs into ones that can be taken orally, marking another triumph in its long-running fight against the pharmaceutical giant.
Alexander J. Hadjis’ decision to head up Sonnenschein Nath & Rosenthal LLP as the national chair of its patent litigation practice has had a domino effect at his office at Weil Gotshal & Manges LLP, with 11 other professionals choosing to pick up and move with him.
A hedge fund is suing a slew of top brokerage firms, saying they used secret insider agreements to cheat their customers.
Medical device maker Medtronic Inc. is charging Kyphon Inc., a maker of spinal fracture treatments, with infringing on four of its patents covering balloon dilation catheters and spinal disc spacing treatment.
Sky Technologies LLC and International Business Machines Corp. have ended their legal battle and reached an agreement in a patent lawsuit involving online business technology that “facilitates multivariate negotiations among two or more parties.”
Following a drawn-out legal dispute with German television mogul Leo Kirch, Deutsche Bank’s Rolf Breuer has stepped down as chairman after a court ruled that he and the bank may be held liable for remarks he made in a 2002 interview, which Kirch claimed triggered the financial collapse of his empire.
In a bizarre investment battle, an offshore investment group and a beverage company are taking swipes at each other amid allegations of share dumping and “financial terrorism.”
The U.S. Court of Appeals for the Federal Circuit has ruled that a case over stent patents should have been filed in Germany, upholding a lower court ruling that deflated the suit brought by a doctor against device makers Pfizer and Boston Scientific.
In agreeing to hear the case between MedImmune and Genentech, the U.S. Supreme Court will set a precedent for whether licensees in good standing are permitted to challenge licensed patents.
A federal judge has ordered barcode equipment maker Metrologic Instruments Inc. to pay a $13.4 million arbitration award to its rival after it allegedly failed to pay royalties on a patent license agreement.
In an attempt to keep a former partner from sinking its teeth into the $5 billion global coronary stent market, Israel’s Medinol Ltd. filed a new legal claim Monday against Boston Scientific Corp. that alleges its stents violate three of Medinol’s patents.
A dispute between the University of Alabama and one of its former professors over biotech patents worth millions of dollars highlights the importance of clear rules about who owns academic inventions, experts say.
Just a few months after medical device maker Medtronic was forced to license spinal fusion patents from a Los Angeles surgeon for a head-spinning $1.35 billion, the company is asserting three of those patents against rival Biomet Inc. and one of its subsidiaries.
Mired in patent lawsuits, medical device maker Medtronic Inc. has decided to pay $37.5 million to settle litigation with its latest accuser, a California biotechnology company that specializes in heart valves.
In a singular victory for News Corp., a Delaware district judge has granted the multinational news giant leave to appeal a key lower court ruling that enabled its shareholders to press on with a class action lawsuit stemming from the company’s anti-takeover measure.
After last year’s record-breaking $1.4 billion payout to a Los Angeles surgeon, medical device maker Medtronic Inc. is now facing charges that it illegally sought patents based on the inventions of a New York orthopedic spine surgeon.
National banks scored an important victory that will minimize state-level lawsuits against them in a U.S. Supreme Court ruling Tuesday that moved a Wachovia Corp. case from a state court to a federal venue and stipulated that other banks with coast-to-coast presence are to be offered the same protection.
Rejecting claims of a contract breach, an Indiana federal judge has ruled against Eli Lilly & Co. in a lawsuit that accused the pharmaceutical giant of stealing technology originally licensed to it by a small biotech company.
In the latest development in its battle with shareholders over its anti-takeover provision, media company News Corp. has asked the Delaware Supreme Court to overturn a lower court ruling that allowed a class action lawsuit against the company to proceed.